 <h1>Cefoxitin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to cefoxitin: intravenous powder for solution, intravenous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, cefoxitin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking cefoxitin:</p><p>
<i>More common</i>
</p><ul>
<li>Changes in skin color</li>
<li>pain</li>
<li>swelling of the foot or leg</li>
<li>tenderness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>coma</li>
<li>confusion</li>
<li>decreased urine output</li>
<li>depression</li>
<li>dizziness</li>
<li>headache</li>
<li>hostility</li>
<li>irritability</li>
<li>lethargy</li>
<li>muscle twitching</li>
<li>nausea</li>
<li>rapid weight gain</li>
<li>seizures</li>
<li>stupor</li>
<li>swelling of the face, ankles, or hands</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach cramps or tenderness</li>
<li>back, leg, or stomach pains</li>
<li>bleeding and bruising</li>
<li>bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloating</li>
<li>bloody or cloudy urine</li>
<li>bloody, black, or tarry stools</li>
<li>chest pain</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>cloudy urine</li>
<li>cough</li>
<li>coughing up blood</li>
<li>cracks in the skin</li>
<li>dark urine</li>
<li>decrease in urine output or decrease in urine-concentrating ability</li>
<li>diarrhea</li>
<li>diarrhea, watery and severe, which may also be bloody</li>
<li>difficult or labored breathing</li>
<li>difficult or painful urination</li>
<li>difficulty with breathing, chewing, swallowing, or talking</li>
<li>dizziness</li>
<li>double vision</li>
<li>drooping eyelids</li>
<li>fast heartbeat</li>
<li>feeling of discomfort</li>
<li>fever</li>
<li>general body swelling</li>
<li>greatly decreased frequency of urination or amount of urine</li>
<li>headache</li>
<li>high fever</li>
<li>hives</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>increased thirst</li>
<li>inflammation of the joints</li>
<li>itching</li>
<li>itching of the vagina or genital area</li>
<li>joint or muscle pain</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of appetite</li>
<li>loss of heat from the body</li>
<li>muscle aches</li>
<li>muscle weakness</li>
<li>nosebleeds</li>
<li>pain during sexual intercourse</li>
<li>pale skin</li>
<li>paralysis</li>
<li>prolonged bleeding from cuts</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>rash</li>
<li>red or black, tarry stools</li>
<li>red or dark brown urine</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>red, swollen skin</li>
<li>scaly skin</li>
<li>severe tiredness</li>
<li>shortness of breath</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>sudden decrease in the amount of urine</li>
<li>swelling of the feet or lower legs</li>
<li>swollen lymph glands</li>
<li>swollen or painful glands</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>tightness in the chest</li>
<li>troubled breathing with exertion</li>
<li>unexplained bleeding or bruising</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>unusual weight loss</li>
<li>vomiting</li>
<li>vomiting of blood</li>
<li>wheezing</li>
<li>yellowing of the eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of cefoxitin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Red streaks on the skin</li>
<li>swelling, tenderness, or pain at the injection site</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Hives or welts</li>
<li>redness of the skin</li>
</ul><p>
<!-- end intravenous powder for solution, intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cefoxitin: injectable powder for injection, intravenous powder for injection, intravenous solution</i></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Induration, pain, pain in the infused vein, phlebitis, tenderness, thrombophlebitis, vein erythema, vein exudates, vein induration<sup>[Ref]</sup></p><p>Phlebitis and thrombophlebitis occurred with IV administration.</p>
<p></p>
<p>Induration, pain, and tenderness occurred in of patients who received IM administration.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Maculopapular rash, rash/skin rashes, urticaria</p>
<p><b>Frequency not reported</b>: Acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS), erythema multiforme, exfoliative dermatitis, pruritus, severe cutaneous adverse reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Rare</b> (0.01% to 0.1%): Diarrhea, nausea, vomiting</p>
<p><b>Frequency not reported</b>: Abdominal pain, colitis, pseudomembranous colitis<sup>[Ref]</sup></p><p>Pseudomembranous colitis may occur during or after treatment.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Agranulocytosis, anemia, aplastic anemia, bone marrow depression, eosinophilia, granulocytopenia, hemolytic anemia, leukocytosis, leukopenia, neutropenia, pancytopenia, positive direct Coombs test, prolonged prothrombin time, thrombocytopenia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (0.01% to 0.1%): Acute renal failure</p>
<p><b>Frequency not reported</b>: Elevation in blood urea nitrogen (BUN), elevation in serum creatinine, interstitial nephritis, prerenal azotemia, renal dysfunction, toxic nephropathy<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Cholestasis, elevated bilirubin, jaundice, liver dysfunction, transient elevations in ALT/AST/serum alkaline phosphatase<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Flushing, hemorrhage, hypotension<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Allergic reactions included anaphylaxis, angioedema, dyspnea, eosinophilia, fever, flushing, interstitial nephritis, pruritus, and skin reactions (e.g., exfoliative dermatitis, maculopapular rash, rash, toxic epidermal necrolysis, urticaria).  Anaphylaxis rarely led to death.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anaphylaxis, angioedema, other allergic reactions<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Serum sickness-like reaction, superinfection<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Death, fever<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: False positive for urinary glucose, transient elevation in LDH<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Vaginitis, vaginitis candidiasis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Seizures<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Myasthenia gravis exacerbation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Mefoxin (cefoxitin)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about cefoxitin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: second generation cephalosporins</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Cefoxitin Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Mefoxin</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Aspiration Pneumonia</li>
<li>Bacterial Infection</li>
<li>Bone infection</li>
<li>Cesarean Section</li>
<li data-more-config-id="list-data-resources-conditions">... +15 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cefoxitin: injectable powder for injection, intravenous powder for injection, intravenous solution</i></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Induration, pain, pain in the infused vein, phlebitis, tenderness, thrombophlebitis, vein erythema, vein exudates, vein induration<sup>[Ref]</sup></p><p>Phlebitis and thrombophlebitis occurred with IV administration.</p><p></p><p>Induration, pain, and tenderness occurred in of patients who received IM administration.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Maculopapular rash, rash/skin rashes, urticaria</p><p><b>Frequency not reported</b>: Acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS), erythema multiforme, exfoliative dermatitis, pruritus, severe cutaneous adverse reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Rare</b> (0.01% to 0.1%): Diarrhea, nausea, vomiting</p><p><b>Frequency not reported</b>: Abdominal pain, colitis, pseudomembranous colitis<sup>[Ref]</sup></p><p>Pseudomembranous colitis may occur during or after treatment.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Agranulocytosis, anemia, aplastic anemia, bone marrow depression, eosinophilia, granulocytopenia, hemolytic anemia, leukocytosis, leukopenia, neutropenia, pancytopenia, positive direct Coombs test, prolonged prothrombin time, thrombocytopenia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (0.01% to 0.1%): Acute renal failure</p><p><b>Frequency not reported</b>: Elevation in blood urea nitrogen (BUN), elevation in serum creatinine, interstitial nephritis, prerenal azotemia, renal dysfunction, toxic nephropathy<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Cholestasis, elevated bilirubin, jaundice, liver dysfunction, transient elevations in ALT/AST/serum alkaline phosphatase<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Flushing, hemorrhage, hypotension<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Allergic reactions included anaphylaxis, angioedema, dyspnea, eosinophilia, fever, flushing, interstitial nephritis, pruritus, and skin reactions (e.g., exfoliative dermatitis, maculopapular rash, rash, toxic epidermal necrolysis, urticaria).  Anaphylaxis rarely led to death.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anaphylaxis, angioedema, other allergic reactions<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Serum sickness-like reaction, superinfection<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Death, fever<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: False positive for urinary glucose, transient elevation in LDH<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Vaginitis, vaginitis candidiasis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Seizures<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Myasthenia gravis exacerbation<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Mefoxin (cefoxitin)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about cefoxitin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: second generation cephalosporins</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Cefoxitin Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Aspiration Pneumonia</li>
<li>Bacterial Infection</li>
<li>Bone infection</li>
<li>Cesarean Section</li>
<li data-more-config-id="list-data-resources-conditions">... +15 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>